Pegaspargase

Details of the Drug

Generic Name:: Pegaspargase
Pronunciation:: peg-AS-par-jase
Drug Type:: Enzyme that prevents cancer cells from surviving
How the Drug is Given:: Intravenously (IV)
Names:: Oncaspar®; PEG-L-asparaginase; Pegaspargase

Indications and Usage

Pegaspargase is FDA approved in combination with other chemotherapy medications to treat people who have acute lymphoblastic leukemia (ALL).

Side effects needing medical attention

Abdominal or stomach pain; blurry vision; constipation; dry mouth and skin; fatigue; increased hunger or thirst; increased need to urinate; nausea; rash; unexplained weight loss; vomiting.

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.